AuntMinnie

SEPTEMBER 25, 2024

Nuclear cardiologists could see significant reductions in Medicare reimbursements in 2025, according to a leading expert. Ultimately, there are “many unknowns” to be explored in the next few months – implications regarding the unknown cost of new diagnostic radiopharmaceuticals, for instance – and the ASNC is in continuing talks with the CMS.

Nuclear Medicine 162

Nuclear Medicine Radiopharmaceuticals Medicare Diagnostic 162

AuntMinnie

MARCH 26, 2025

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) presented its 2025 Legislative Champion Award to Representatives Neal Dunn, MD, and Ami Bera, MD. Centers for Medicare and Medicaid (CMS) to update the Hospital Outpatient Prospective Payment System (HOPPS) in 2025 by unbundling radiopharmaceuticals.

Nuclear Medicine 130

Nuclear Medicine Radiopharmaceuticals Medicare Diagnostic 130

AuntMinnie

MARCH 27, 2025

Flyrcadois a unit-dose PET myocardial perfusion imaging (MPI) agent intended for patients with known or suspected coronary artery disease. GE HealthCare's launch coincides with the receipt of pass-through status by the Centers for Medicare & Medicaid Services (CMS), effectiveApril 1st. The company received approval from the U.S.

Healthcare 147

Healthcare Healthcare Medicare Radiopharmaceuticals 147

AuntMinnie

JANUARY 11, 2024

The Centers for Medicare and Medicaid Services (CMS) has established a national payment rate for RefleXion Medical's Scintix biology-guided radiotherapy system. RefleXion said while other technologies use anatomical images to guide radiotherapy delivery, Scintix therapy is the only radiotherapy to use emissions from cancer cells.

Radiopharmaceuticals 130

Radiopharmaceuticals Medicare Radiation Hospital 130

Imaging Technology

JANUARY 30, 2025

30, 2025 Earlier this month, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Thu, 01/30/2025 - 10:20 Jan.30,

Nuclear Medicine 52

Nuclear Medicine Imaging Patient Care Disease 52

Imaging Technology

JUNE 21, 2023

POSLUMA (formerly referred to as to as 18F-rhPSMA-7.3 ) is an optimized, high-affinity radiohybrid (rh) Prostate-Specific Membrane Antigen (PSMA)-targeted PET imaging agent. Additional PETNET sites are expected to manufacture POSLUMA before the end of the summer. “We

Diagnostic 97

Diagnostic Radiopharmaceuticals Imaging Medicare 97

Imaging Technology

JANUARY 12, 2024

a therapeutic oncology company, announced that the Centers for Medicare and Medicaid Services (CMS) has established a national payment rate for RefleXion’s SCINTIX biology-guided radiotherapy using CMS’ New Technology (NT) Ambulatory Payment Classification (APC) pathway. 1, 2024, to describe SCINTIX therapy.

Radiopharmaceuticals 105

Radiopharmaceuticals Radiation Medicare Clinic 105

Imaging Technology

JULY 20, 2023

He previously served on the ASTRO Board as head of the Government Relations Council, helping lead ASTRO’s work with Congress and other policymakers on prior authorization and Medicare payment reform.

Radiation Oncology 98

Radiation Oncology Radiation Government Community Practice 98

AuntMinnie

OCTOBER 2, 2024

The following is the list of candidates for the 2024 edition of the Minnies, AuntMinnie.com 's campaign to recognize the best and brightest in medical imaging. Image from Martin W. Image from Denis Le Bihan, PhD, of the NeuroSpin research facility, et al. Image from Richard Carson, PhD, of Yale University, et al.

Digital Imaging and Communications in Medicine 360

Digital Imaging and Communications in Medicine X-ray MRI Hospital 360

AuntMinnie

JANUARY 19, 2024

The promise of imaging One challenge is that advances in Alzheimer’s care can only help people if they are reaching the right patients at the right time in their patient journey. Reimbursement barriers Unfortunately, until recently, there were significant barriers to receiving amyloid PET imaging in some regions.

Disease 130

Disease Imaging Medicare PET Scan 130

Imaging Technology

MAY 23, 2023

The new ASTRO survey illustrates how staffing issues exacerbate the pressures that radiation oncology clinics face due to ongoing and excessive cuts to Medicare reimbursements, burdensome prior authorization requirements, and rising costs and inflation. in Medicare payment policies. Mike Kelly (R-Penn.), Ami Bera, MD (D-Calif.)

Radiation Oncology 96

Radiation Oncology Radiation Clinic Medicare 96

AuntMinnie

JANUARY 8, 2025

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association have released new appropriate use criteria for brain PET imaging of amyloid and tau pathology related to cognitive impairment and Alzheimers disease. Since then, the U.S. There are three PET radiotracers labeled with F-18 approved by the U.S.

Nuclear Medicine 290

Nuclear Medicine Imaging Radiopharmaceuticals Medicare 290

Imaging Technology

JANUARY 14, 2025

8, 2025 The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association have released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Tue, 01/14/2025 - 16:48 Jan.8, Since then, the U.S.

Nuclear Medicine 52

Nuclear Medicine Imaging Patient Care PET Scan 52